SCHEMBL28020044

SCHEMBL28020044

N#Cc1cccc([N+](=O)[O-])c1N1CCOCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.50
CYP2C9 P11712 1/20 0.50
CTSB P07858 3/20 0.47
CTSL P07711 2/20 0.46
CTSS P25774 2/20 0.46
CTSK P43235 2/20 0.46
MAPT P10636 8/20 0.45
PKM P14618 2/20 0.45
ALDH1A1 P00352 5/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
TDP1 Q9NUW8 2/20 0.43
LMNA P02545 2/20 0.43
KMT2A Q03164 2/20 0.43
POLB P06746 1/20 0.43
ATM Q13315 1/20 0.43
MAPK1 P28482 1/20 0.43
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28333188 0.86 ALDH1A1 (0.57) CYP1A2CYP2C9CTSBMAPTPKM
SCHEMBL4001383 0.83 CTSL (0.46) CTSBCTSLCTSSCTSKMAPT
SCHEMBL3984049 0.78 CYP1A2 (0.54) CYP1A2CYP2C9CTSBMAPTPKM
SCHEMBL17651460 0.78 ALDH1A1 (0.63) CYP1A2CYP2C9CTSBMAPTPKM
SCHEMBL3723155 0.78 CYP1A2 (0.54) CYP1A2CYP2C9CTSBMAPTPKM
SCHEMBL30457932 0.78 ALDH1A1 (0.63) CYP1A2CYP2C9CTSBMAPTPKM
SCHEMBL31226524 0.78 CYP1A2 (0.54) CYP1A2CYP2C9CTSBMAPTPKM
SCHEMBL5235027 0.78 ALDH1A1 (0.59) CYP1A2CYP2C9CTSBMAPTPKM
SCHEMBL249019 0.77 ALDH1A1 (0.49) CYP1A2CYP2C9CTSBMAPTPKM
SCHEMBL1424205 0.76 ALDH1A1 (0.50) CYP1A2CYP2C9CTSBMAPTPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104761541-A Inhibitors of the Interaction Between MDM2 and P53 JANSSEN PHARMACEUTICA NV 2015-07-08 CN disclosed